[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Iron Chelation Drug Market Data Survey Report 2025

August 2017 | 86 pages | ID: GF3E6B77A29EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is 1000 ?g/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.

The global Iron Chelation Drug market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Apotex Inc. (Canada)
  • Cipla (India)
  • Novartis (Switzerland)
  • Sun Pharma (India)
  • Natco Pharma (India)

Major applications
as follows:
  • Transfusional Iron Overload
  • NTDT Caused Iron Overload
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Apotex Inc. (Canada)
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Cipla (India)
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Novartis (Switzerland)
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sun Pharma (India)
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Natco Pharma (India)
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Transfusional Iron Overload
  4.1.1 Overview
  4.1.2 Transfusional Iron Overload Market Size and Forecast
4.2 NTDT Caused Iron Overload
  4.2.1 Overview
  4.2.2 NTDT Caused Iron Overload Market Size and Forecast

5 MARKET PRICE

5.1 Overview
5.2 Price by SUK

6 CONCLUSION

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Apotex Inc. (Canada)
Tab Sales Revenue, Volume, Price, Cost and Margin of Cipla (India)
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis (Switzerland)
Tab Sales Revenue, Volume, Price, Cost and Margin of Sun Pharma (India)
Tab Sales Revenue, Volume, Price, Cost and Margin of Natco Pharma (India)
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)

LIST OF FIGURES

Fig Global Iron Chelation Drug Market Size and CAGR 2011-2017 (Value)
Fig Global Iron Chelation Drug Market Size and CAGR 2011-2017 (Volume)
Fig Global Iron Chelation Drug Market Forecast and CAGR 2018-2025 (Value)
Fig Global Iron Chelation Drug Market Forecast and CAGR 2018-2025 (Volume)
Fig Transfusional Iron Overload Market Size and CAGR 2011-2017 (Value)
Fig Transfusional Iron Overload Market Size and CAGR 2011-2017 (Volume)
Fig Transfusional Iron Overload Market Forecast and CAGR 2018-2025 (Value)
Fig Transfusional Iron Overload Market Forecast and CAGR 2018-2025 (Volume)
Fig NTDT Caused Iron Overload Market Size and CAGR 2011-2017 (Value)
Fig NTDT Caused Iron Overload Market Size and CAGR 2011-2017 (Volume)
Fig NTDT Caused Iron Overload Market Forecast and CAGR 2018-2025 (Value)
Fig NTDT Caused Iron Overload Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025


More Publications